Browsing Tag
Vistagen Therapeutics
1 post
Vistagen shares topline PALISADE-3 Phase 3 data for fasedienol in acute social anxiety treatment
Find out how Vistagen’s PALISADE-3 Phase 3 results for fasedienol reshape its social anxiety strategy and investor expectations.